Business Information

Helena W. Rodbard; Lawrence Blonde; Susan S. Braithwaite; Elise M. Brett; Rhoda H. Cobin; Yehuda Handelsman; Richard Hellman; Paul S. Jellinger; Lois Jovanovič; Philip T. Levy; Jeffrey I. Mechanick; Farhad Zangeneh

doi:10.4158/ep.13.s1.1

Keywords

Medicine

Related Publications

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

Scott M. Grundy

2006 Nature Reviews Drug Discovery 283 citations

SGLT-2 inhibitors: Their pleiotropic properties

Natalia G. Vallianou , Eleni Geladari , Christos Kazazis

2016 Diabetes & Metabolic Syndrome Clinica... 29 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

1998 The Lancet 8193 citations

Plasma Insulin Responses to Glucose and Tolbutamide of Normal Weight and Obese Diabetic and Nondiabetic Subjects

Michael Perley , David Kipnis

Plasma insulin responses to oral glucose (100 gm.) and intravenous tolbutamide (1.0 gm.) before and after dexamethasone were determined in normal, obese nondiabetic, normal-weig...

1966 Diabetes 333 citations

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

Michael A. Nauck , Daniel R. Quast , Jakob Wefers +1 more

2020 Molecular Metabolism 1286 citations

Publication Info

Year: 2007
Type: article
Volume: 13
Pages: 2-2
Citations: 698
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Business Information

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

698

OpenAlex

Cite This

APA Style

                            
                                    Helena W. Rodbard, 
                                
                                    Lawrence Blonde, 
                                
                                    Susan S. Braithwaite
                                
                                et al.
                            
                            (2007). 
                            Business Information. 
                            Endocrine Practice
                            , 13
                            
                            , 2-2.
                            https://doi.org/10.4158/ep.13.s1.1

Identifiers

DOI: 10.4158/ep.13.s1.1